Inflammatory protein serum amyloid A1 marks a subset of conventional renal cell carcinomas with fatal outcome

Background - Conventional renal cell carcinoma (RCC) is the most common renal cancer. As the metastatic conventional RCC is practically incurable, there is a need for markers to estimate the tumour aggressiveness. - Objective - To identify and characterise new marker(s) associated with the poor prog...

Full description

Saved in:
Bibliographic Details
Main Authors: Paret, Claudia (Author) , Schön, Zorica (Author) , Szponar, Adrianna (Author) , Kovacs, Gyula (Author)
Format: Article (Journal)
Language:English
Published: 2010
In: European urology
Year: 2010, Volume: 57, Issue: 5, Pages: 859-866
ISSN:1873-7560
DOI:10.1016/j.eururo.2009.08.014
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.eururo.2009.08.014
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0302283809008562
Get full text
Author Notes:Claudia Paret, Zorica Schön, Adrianna Szponar, Gyula Kovacs

MARC

LEADER 00000caa a2200000 c 4500
001 1850960682
003 DE-627
005 20230710125515.0
007 cr uuu---uuuuu
008 230626s2010 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.eururo.2009.08.014  |2 doi 
035 |a (DE-627)1850960682 
035 |a (DE-599)KXP1850960682 
035 |a (OCoLC)1389793905 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Paret, Claudia  |e VerfasserIn  |0 (DE-588)1181385490  |0 (DE-627)1662666837  |4 aut 
245 1 0 |a Inflammatory protein serum amyloid A1 marks a subset of conventional renal cell carcinomas with fatal outcome  |c Claudia Paret, Zorica Schön, Adrianna Szponar, Gyula Kovacs 
264 1 |c 2010 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar 27 August 2009 
500 |a Gesehen am 26.06.2023 
520 |a Background - Conventional renal cell carcinoma (RCC) is the most common renal cancer. As the metastatic conventional RCC is practically incurable, there is a need for markers to estimate the tumour aggressiveness. - Objective - To identify and characterise new marker(s) associated with the poor prognosis of conventional RCC. - Design, Setting, and Participants - RNA from 24 conventional RCCs was analysed for global gene expression by Affymetrix U133 Plus 2.0 arrays. Tissue microarrays containing 224 renal tumours including 87 conventional RCCs were used for immunohistochemistry. Cell lines HD2, HD48, HA344 and HA465 established in our laboratory were used for invasion assay and zymography. - Measurements - Serum amyloid A 1 (SAA1) was found to be upregulated in conventional RCCs and it has been analysed by quantitative RT-PCR and immunohistochemistry on TMAs to establish the correlation between SAA1 protein expression and patient survival by uni and multivariate analysis. The effect of SAA1 on tumour cell behaviour in vitro has also been examined by invasion assay and zymography. - Results and Limitations - SAA1 RNA is expressed in conventional RCC samples of patients with poor prognosis. Immunohistochemistry of 72 conventional RCCs with a 5 yr follow up showed a correlation between SAA1 expression and the clinical outcome of disease. Stimulation of conventional RCC cell lines with recombinant SAA1 increased the expression of metalloproteinase (MMP)-9 and the invasive potential of tumour cells. Limitation of the study is a relatively small number (72) of patients having follow up. - Conclusion - SAA1 seems to be a useful marker to estimate the prognosis of conventional RCCs. 
650 4 |a Conventional RCC 
650 4 |a Metastasis 
650 4 |a MMP 
650 4 |a SAA1 
650 4 |a TMA 
700 1 |a Schön, Zorica  |e VerfasserIn  |4 aut 
700 1 |a Szponar, Adrianna  |d 1982-  |e VerfasserIn  |0 (DE-588)140792597  |0 (DE-627)621611409  |0 (DE-576)320797163  |4 aut 
700 1 |a Kovacs, Gyula  |e VerfasserIn  |0 (DE-588)1081747579  |0 (DE-627)846587424  |0 (DE-576)454756399  |4 aut 
773 0 8 |i Enthalten in  |t European urology  |d Amsterdam [u.a.] : Elsevier Science, 1976  |g 57(2010), 5 vom: Mai, Seite 859-866  |h Online-Ressource  |w (DE-627)300191596  |w (DE-600)1482253-2  |w (DE-576)099718103  |x 1873-7560  |7 nnas  |a Inflammatory protein serum amyloid A1 marks a subset of conventional renal cell carcinomas with fatal outcome 
773 1 8 |g volume:57  |g year:2010  |g number:5  |g month:05  |g pages:859-866  |g extent:8  |a Inflammatory protein serum amyloid A1 marks a subset of conventional renal cell carcinomas with fatal outcome 
856 4 0 |u https://doi.org/10.1016/j.eururo.2009.08.014  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0302283809008562  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230626 
993 |a Article 
994 |a 2010 
998 |g 1081747579  |a Kovacs, Gyula  |m 1081747579:Kovacs, Gyula  |d 50000  |e 50000PK1081747579  |k 0/50000/  |p 4  |y j 
998 |g 140792597  |a Szponar, Adrianna  |m 140792597:Szponar, Adrianna  |d 50000  |e 50000PS140792597  |k 0/50000/  |p 3 
999 |a KXP-PPN1850960682  |e 4343417182 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Online verfügbar 27 August 2009","Gesehen am 26.06.2023"],"physDesc":[{"extent":"8 S."}],"relHost":[{"recId":"300191596","id":{"issn":["1873-7560","1421-993X"],"eki":["300191596"],"zdb":["1482253-2"]},"origin":[{"publisherPlace":"Amsterdam [u.a.] ; Basel","dateIssuedDisp":"1976-","publisher":"Elsevier Science ; Karger","dateIssuedKey":"1976"}],"pubHistory":["Nachgewiesen 2.1976 -"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"extent":"8","text":"57(2010), 5 vom: Mai, Seite 859-866","volume":"57","pages":"859-866","year":"2010","issue":"5"},"note":["Ungezählte Beil. bis 40.2001: Supplement"],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"subtitle":"official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology","title":"European urology","title_sort":"European urology"}],"language":["eng"],"disp":"Inflammatory protein serum amyloid A1 marks a subset of conventional renal cell carcinomas with fatal outcomeEuropean urology"}],"language":["eng"],"origin":[{"dateIssuedDisp":"2010","dateIssuedKey":"2010"}],"person":[{"display":"Paret, Claudia","roleDisplay":"VerfasserIn","given":"Claudia","family":"Paret","role":"aut"},{"role":"aut","family":"Schön","roleDisplay":"VerfasserIn","display":"Schön, Zorica","given":"Zorica"},{"roleDisplay":"VerfasserIn","given":"Adrianna","display":"Szponar, Adrianna","family":"Szponar","role":"aut"},{"family":"Kovacs","given":"Gyula","roleDisplay":"VerfasserIn","display":"Kovacs, Gyula","role":"aut"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"Inflammatory protein serum amyloid A1 marks a subset of conventional renal cell carcinomas with fatal outcome","title_sort":"Inflammatory protein serum amyloid A1 marks a subset of conventional renal cell carcinomas with fatal outcome"}],"recId":"1850960682","id":{"eki":["1850960682"],"doi":["10.1016/j.eururo.2009.08.014"]},"name":{"displayForm":["Claudia Paret, Zorica Schön, Adrianna Szponar, Gyula Kovacs"]}} 
SRT |a PARETCLAUDINFLAMMATO2010